Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors | MicrobiomeTrials← Back to trialsNCT06646627
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-11-11Est. Completion: 2027-01
Enrollment target: 48 participants Locations- Stanford University, Palo Alto, California, United States
Other microbiome trials you might be interested in
Hormone Receptor-Positive Breast CancerHER2 Low Breast CarcinomaEarly-Stage Breast Cancer
This is a single-center, open-label, randomized phase II clinical trial designed to evaluate the efficacy and safety of …
Guangzhou, ChinaEst. completion Sep 15, 2028
Ovarian CancerGenetic TestingGenetic Counseling
The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after vi…
Lexington, United StatesEst. completion Jul 2027